Skip to main content

Table 1 Demographics of SLE and RA patients and healthy donors

From: Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients

  SLE patients (n = 67) RA patients (n = 20) Healthy donors (n = 23)
Age (years) 35.43 ± 1.85 (14–60) 37.2 ± 1.68 (17–61) 32.21 ± 2 (16–58)
Sex (%)    
   Female 89.6 85 83.3
   Male 10.4 15 16.7
Disease duration (years) 5.58 ± 0.75 (0.04–24) 5.93 ± 1.3 (1.2–21) -
ANA (%) 95.5 37.1 -
SLEDAI-2K 8.06 ± 0.68 (0–25) - -
SDI 0.82 ± 0.17 (0–6) - -
  1. Except where otherwise indicated, values are expressed as mean ± standard error of the mean (range). There were no significant differences between patients with SLE, patients with RA and healthy donors in terms of age and sex. ANA, antinuclear antibody; RA, rheumatoid arthritis; SDI, Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index; SLE, systemic lupus erythematosus; SLEDAI-2K, SLE Disease Activity Index 2000.